Yahoo Web Search

Search results

  1. People also ask

  2. Oct 1, 2019 · The goal of a palliative course of radiation therapy is to minimize toxicity, and as such, IMRT should be considered, given its greater ability to spare critical structures in the head and neck from radiation dose than less conformal techniques.

  3. Palliative surgery should be considered in selected cases. (R) • Hypofractionated or short course radiotherapy should be considered for local pain control and for painful bony metastases. (R) • All palliative patients should have a functional endoscopic evaluation of swallowing (FEES) assessment of swallow to assess for risk of ...

  4. Treatment may take 4 to 7 weeks, depending on the type and size of the cancer. If you are having palliative radiotherapy, you may have a single treatment or 1 to 3 weeks of treatment. Your cancer doctor (clinical oncologist), specialist nurse, or radiographer will discuss the treatment with you.

  5. Mar 23, 2018 · Palliative radiotherapy offers effective symptom control for focal disease due to cancer. Increased analgesia, anti-emetics, and in some cases corticosteroids can help to reduce discomfort and side effects. Acute side effects of radiotherapy usually resolve within 4-6 weeks of completing treatment.

  6. Oct 1, 2019 · An ideal palliative radiation regimen should alleviate symptoms secondary to the cancer with minimal treatment toxicity and side effects while improving a patient's quality of life.

    • Amardeep S. Grewal, Joshua Jones, Alexander Lin
    • 2019
  7. Palliative radiotherapy may be considered as initial treatment for those with locally advanced disease not amenable to radical treatment or patients with poor performance status. Radiotherapy doses are governed by the respective Q Pulse Documents on radiotherapy protocols.

  8. Jun 26, 2023 · The objective to assess the outcomes from different palliative radiotherapy (RT) schedules in incurable head and neck cancer (HNC), to evaluate if there is a relationship between RT dose, technique, and fractionation with tumor response in contrast to the occurrence of adverse effects.